TP53 and glioblastoma: Among these, Buparlisib (BKM120) is an oral bioavailable pan-PI3K inhibitor, which induces G2/M cell cycle arrest and apoptosis in GBM cells via microtubule misalignment and mitotic disruption in a p53-dependent manner [126].